Prospective Grant of Exclusive Patent License

The National Institute of Standards and Technology (NIST), U.S. Department of Commerce, is contemplating the grant of an exclusive license in the United States of America, its territories, possessions and commonwealths, to NIST's interest in the invention embodied in U.S. 10,153,144, titled “Imaging Spectrometer” (NIST Docket 15-037-CIP) to CAMECA Instruments Inc. The grant of the license would be for manufacture and sale of extreme ultraviolet spectrometers.DATES:The prospective exclusive license may be granted unless NIST receives, by April 17, 2020, written evidence and argument which establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. ADDRESSES: Information related to this license may be submitted to NIST, Technology Partnerships Office, 100 Bureau Drive, Stop 2200, Gaithersburg, MD 20899, or emailed to donald.archer@nist.gov.FOR FURTHER INFORMATION

CONTACT:Donald G. Archer, National Institute of Standards and Technology, Technology Partnerships Office, 100 Bureau Drive, Stop 2200, Gaithersburg, MD 20899, (301) 975-2522, donald.archer@nist.gov.SUPPLEMENTARY INFORMATION:This is a notice in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i) that NIST is contemplating the grant of an exclusive license in the United States of America, its territories, possessions and commonwealths, to NIST's interest in the invention embodied in U.S. Patent 10,153,144, titled “Imaging Spectrometer” (NIST Docket 15-037-CIP) to CAMECA Instruments Inc.. The grant of the license would be for manufacture and sale of extreme ultraviolet spectrometers.The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within fifteen (15) days from the date of this published Notice, NIST receives written evidence and argument which establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The Patent Application was filed on June 26, 2017 and describes extreme ultraviolet spectrometers which can be used for determining a chemical map of a sample of hard matter or soft matter.